Received by email:

File: XCX_News Release_ Share Split and Market Maker_16nov18.docx


Chinook Proposes Share Split and Retains Market Making Services

VANCOUVER, BRITISH COLUMBIA, November 16, 2018 | Chinook Tyee Industry Limited (the "Company") (TSXV: XCX), announces 
--->a proposed three-for-one share split (the "Share Split") of its issued and outstanding common shares (each a "Pre-Spli
--->t") in order to enhance the liquidity and encourage a wider distribution of the Company's common shares.  The Share Sp
--->lit is subject to the approval of both Company shareholders at its annual general and special shareholders' meeting to
---> be held on December 5, 2018, and the TSX Venture Exchange ("TSXV").

Upon completion of the Share Split, the Company will have 10,217,796 Post-Split fully diluted common shares outstandin
--->g. The Company currently has 3,405,932 Pre-Split fully diluted common shares outstanding.
The Company also announces that it has, subject to regulatory approval, retained Venture Liquidity Providers Inc. ("VL
--->P") to initiate market-making services to provide assistance in maintaining an orderly trading market for the Company'
--->s common shares.
The market-making service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Ltd. ("WD Latimer"),
---> in compliance with the applicable policies of the TSXV and other applicable laws.  For its services, VLP and the Comp
--->any have entered into a yearly contract for a monthly fee of $5,000, which can be terminated at any time by either par
--->ty.  The Company and VLP act at arm's length, and VLP has no present interest, directly or indirectly, in the Company 
--->or its securities. The finances and the shares required for the market making service are provided by W.D. Latimer.  T
--->he fee paid by the Company to VLP is for services only. 
About Chinook Tyee Industry Limited 
Chinook Tyee Industry Limited is a TSX Venture listed holding company with two European subsidiaries:  AMP Alternative
---> Medical Products GmbH, a German private company focused on providing medical cannabis formulations and dose delivery 
--->systems for German patients, with offices in Berlin and Erfurt, Germany (amp-eu.com) and Mercury Partners & Company pl
--->c, a Malta public liability investment holding company with an office in Valletta, Malta (mercurypartners.eu).   
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.  

Neither the TSXV nor its Regulation Service Provider (as that term is defined in the policies of the TSXV) accepts res
--->ponsibility for the adequacy or accuracy of this release.

For further information, please contact:
 Alex Blodgett 
Tel: +1 (236) 833-1602
Email: investor@amp-eu.com